Article

MRI helps guide rotator cuff tear management

MRI may be used to monitor rotator cuff changes and guide management in long-term follow-up of patients with tears who are treated nonoperatively. Factors associated with tear progression include age older than 60 years, a full-thickness tear, and fatty infiltration of the rotator cuff muscles.

MRI may be used to monitor rotator cuff changes and guide management in long-term follow-up of patients with tears who are treated nonoperatively. Factors associated with tear progression include age older than 60 years, a full-thickness tear, and fatty infiltration of the rotator cuff muscles.

Maman and associates retrospectively analyzed 59 shoulders in 54 patients. They examined MRI scans to determine whether the tear remained stable or changed (growth or shrinkage of more than 5 mm) and compared the extent of change with respect to a variety of factors.

Progression in tear size occurred more often in patients who were monitored for more than 18 months. There were 13 shoulders with tears in 12 patients (54%) in the older group and 6 shoulders in 6 patients (17%) in the younger group. Full-thickness tears were seen in 33 shoulders (56%); 12 had not undergone change, 17 increased in size, and 4 decreased. No tears that involved more than 1 tendon became smaller. An increase in tear size was more common in shoulders with fatty infiltration than in those without.

The authors noted that in the absence of clinical symptoms, the role of routine screening should be a topic of future research.

Related Videos
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
Søren Andreas Just, MD, PhD: Developing AI to Mitigate Rheumatologist Shortages for Disease Assessment
© 2024 MJH Life Sciences

All rights reserved.